Primary aldosteronism and malignant adrenocortical neoplasia.
Our experience indicates that although adrenal carcinoma is not a common cause of primary aldosteronism, 4 to 5% of patients in a single large series may have a malignant adrenocortical tumor. The magnitude of the hypokalemia and the hyperaldosteronuria tends to be greater in patients with malignant tumors, but these patients cannot be clearly separated from those with benign tumors or hyperplasia on this basis. Patients who have malignant tumors may have no chemical evidence of adrenocortical dysfunction other than excessive aldosterone secretion. Finally, a good response to spironolactone for months does not exclude adrenal carcinoma as the cause of primary aldosteronism.
D000236:Adenoma / Q000150:complications*; D000306:Adrenal Cortex Neoplasms / Q000150:complications*; D000310:Adrenal Gland Neoplasms / Q000150:complications*; D002277:Carcinoma / Q000150:complications*; D006801:Humans; D006929:Hyperaldosteronism / Q000209:etiology*; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011379:Prognosis